Abstract:BACKGROUND:MicroRNAs (miRNAs) serve as important regulators of the tumorigenesis and progression of many human cancers. Therefore, we evaluated the biological function and underlying mechanism of miR-363 in clear cell renal cell carcinoma (ccRCC).METHODS:The expression of miR-363 in ccRCC tissues compared with adjacent normal renal tissues was detected by quantitative real-time polymerase chain reaction, and the association between miR-363 levels and prognosis of ccRCC patients was analyzed. The candidate target gene of miR-363 was determined by in silico analysis and luciferase reporter assays. The effects of miR-363 on the proliferation, migration and invasion of ccRCC cells in vitro were determined by MTS assay, colony formation assay, Transwell assay and wound healing assay. We also investigated the roles of miR-363 in vivo by a xenograft tumour model. The mechanism of miR-363 on the proliferation, migration and invasion of ccRCC was determined by gain- and loss-of-function analyses.RESULTS:we demonstrated that miR-363 expression was obviously downregulated in ccRCC tissues and that reduced miR-363 expression was correlated with poor disease-free survival (DFS) in ccRCC patients after surgery. S1PR1 expression was inversely correlated with the level of miR-363 in human ccRCC samples. Luciferase reporter assays suggested that S1PR1 was a direct functional target of miR-363. miR-363 downregulated S1PR1 expression and suppressed the proliferation, migration and invasion abilities of ccRCC cells in vitro and suppressed xenograft tumour growth in vivo. Importantly, miR-363 exerted its biological function by inhibiting S1PR1 expression in ccRCC cells, leading to the repression of ERK activation. Moreover, we found that the levels of downstream effectors of ERK, including PDGF-A, PDGF-B, and epithelial-mesenchymal transition (EMT)-related genes, were decreased after miR-363 overexpression.CONCLUSIONS:Our results suggest that miR-363 acts as a tumour suppressor by directly targeting S1PR1 in ccRCC and may be a potential new therapeutic target for ccRCC.

Mir-625-3p Promotes Migration and Invasion and Reduces Apoptosis of Clear Cell Renal Cell Carcinoma.

Oncogenic Mir-425-5p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

MiR-625-3p promotes cell migration and invasion via inhibition of SCAI in colorectal carcinoma cells.

Mir-125B is Associated with Renal Cell Carcinoma Cell Migration, Invasion and Apoptosis

Mir-363 Suppresses the Proliferation, Migration and Invasion of Clear Cell Renal Cell Carcinoma by Downregulating S1PR1.

Mir-155-5p Promotes Cell Proliferation and Migration of Clear Cell Renal Cell Carcinoma by Targeting PEG3.

Downregulation of Transmembrane Protein 40 by Mir-138-5p Suppresses Cell Proliferation and Mobility in Clear Cell Renal Cell Carcinoma.

The Putative Tumor Suppressor Microrna-30A-5p Modulates Clear Cell Renal Cell Carcinoma Aggressiveness Through Repression of ZEB2

Identification of Mir-195-3p As an Oncogene in RCC

MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key Mirnas

Mir-19A Correlates with Poor Prognosis of Clear Cell Renal Cell Carcinoma Patients Via Promoting Cell Proliferation and Suppressing PTEN/SMAD4 Expression.

Oncogenic Microrna-142-3p is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma.

Mir-203a-5p Suppresses Cervical Cancer Cell Tumorigenesis And Emt Via Targeting Mapk1

Mir-654-3p Predicts the Prognosis of Hepatocellular Carcinoma and Inhibits the Proliferation, Migration, and Invasion of Cancer Cells

MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4.

Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.

Oncogenic microRNA-1423 p is associated with cellular migration , proliferation and apoptosis in renal cell carcinoma

Tumor Suppressive Mir-196A is Associated with Cellular Migration, Proliferation and Apoptosis in Renal Cell Carcinoma

Mir-30A-3p Inhibits Renal Cancer Cell Invasion and Metastasis Through Targeting ATG12.

miR-625 suppresses cell proliferation and migration by targeting HMGA1 in breast cancer

MiR-23a-3p Acts As an Oncogene and Potential Prognostic Biomarker by Targeting PNRC2 in RCC.